LIPO
Income statement / Annual
Last year (2023), Lipella Pharmaceuticals Inc.'s total revenue was $449,617.00,
an increase of 144.15% from the previous year.
In 2023, Lipella Pharmaceuticals Inc.'s net income was -$4.62 M.
See Lipella Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$449,617.00 |
$184,156.00 |
$259,347.00 |
$961,683.00 |
$694,748.00 |
| Cost of Revenue |
$3.04 M
|
$2.55 M
|
$1.46 M
|
$975,960.00
|
$682,891.00
|
| Gross Profit |
-$2.59 M
|
-$2.36 M
|
-$1.20 M
|
-$14,277.00
|
$11,857.00
|
| Gross Profit Ratio |
-5.76
|
-12.83
|
-4.62
|
-0.01
|
0.02
|
| Research and Development Expenses |
$3.04 M
|
$2.55 M
|
$1.46 M
|
$975,960.00
|
$682,891.00
|
| General & Administrative Expenses |
$2.16 M
|
$226,192.00
|
$718,384.00
|
$42,585.00
|
$65,648.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.16 M
|
$226,192.00
|
$718,384.00
|
$42,585.00
|
$65,648.00
|
| Other Expenses |
$0.00
|
-$45.00
|
$57,085.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.16 M
|
$2.77 M
|
$2.18 M
|
$1.02 M
|
$748,539.00
|
| Cost And Expenses |
$5.20 M
|
$2.77 M
|
$2.18 M
|
$1.02 M
|
$748,539.00
|
| Interest Income |
$137,836.00
|
$1,678.00
|
$104.00
|
$3,171.00
|
$334.00
|
| Interest Expense |
$10,848.00
|
$9,612.00
|
$6,834.00
|
$7,965.00
|
$8,391.00
|
| Depreciation & Amortization |
$1,685.00
|
$2.59 M
|
$1.92 M
|
$56,862.00
|
$53,791.00
|
| EBITDA |
-$4.61 M |
-$2.59 M |
$0.00 |
-$53,691.00 |
$334.00 |
| EBITDA Ratio |
-10.25
|
-14.05
|
-7.17
|
-0.06
|
-0.08
|
| Operating Income Ratio |
-10.56
|
-14.06
|
-7.39
|
-0.06
|
-0.08
|
| Total Other Income/Expenses Net |
$126,988.00
|
-$7,979.00
|
$50,355.00
|
-$4,794.00
|
-$8,058.00
|
| Income Before Tax |
-$4.62 M
|
-$2.60 M
|
-$1.87 M
|
-$61,656.00
|
-$61,848.00
|
| Income Before Tax Ratio |
-10.27
|
-14.11
|
-7.19
|
-0.06
|
-0.09
|
| Income Tax Expense |
$0.00
|
-$1,633.00
|
$6,730.00
|
$4,794.00
|
-$53,791.00
|
| Net Income |
-$4.62 M
|
-$2.60 M
|
-$1.87 M
|
-$66,450.00
|
-$61,848.00
|
| Net Income Ratio |
-10.27
|
-14.1
|
-7.22
|
-0.07
|
-0.09
|
| EPS |
-6.16 |
-0.45 |
-0.33 |
-0.0117 |
-0.0109 |
| EPS Diluted |
-0.77 |
-0.45 |
-0.33 |
-0.0117 |
-0.0109 |
| Weighted Average Shares Out |
$750,384.00
|
$5.74 M
|
$5.74 M
|
$5.69 M
|
$5.69 M
|
| Weighted Average Shares Out Diluted |
$6.00 M
|
$5.74 M
|
$5.74 M
|
$5.69 M
|
$5.69 M
|
| Link |
|
|
|
|
|
